Active substance
Nitrofurantoin
- SFDA 2
- US FDA 21
- Health Canada 9
- US price lines 5
- NHS prices 6
- WHO EML 1
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| UVAMIN 100MG RETARD CAPSULES | 100 mg | Capsule, hard · Oral use | 20 Blister | SAR 27.25 | Generic · Prescription | ACINO PHARMA AG | Valid |
| COLIFURAN TAB 100MG | 100 mg | Tablet · Oral use | 20 Blister | SAR 11.05 | NCE · Prescription | KAHIRA EYGEPT | Withdrawn by regulatory authority · Not Marketed |
Indications — CHI Daman Drug Formulary
LOWER URINARY TRACT INFECTIONS; RECURRENT URINARY TRACT INFECTIONS (UTI)
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FURADANTIN | 25MG/5ML; 50MG/5ML | suspension · oral | CASPER PHARMA LLC | Prescription | 23 Dec 1953 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | STRIDES PHARMA | Prescription | 14 Aug 2013 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | NOVEL LABS INC | Prescription | 8 Sep 2014 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | ACTAVIS MID ATLANTIC | Prescription | 3 May 2016 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | NOVITIUM PHARMA | Prescription | 14 Apr 2023 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | AUROBINDO PHARMA | Prescription | 11 May 2023 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | BIOCON PHARMA | Prescription | 28 Oct 2024 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | SOMERSET THERAPS LLC | Prescription | 14 Jan 2025 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | ANNORA PHARMA | Prescription | 2 Jul 2025 |
| FURADANTIN | 50MG; 100MG | tablet · oral | PROCTER AND GAMBLE | Discontinued | 6 Feb 1953 |
| IVADANTIN | EQ 180MG BASE/VIAL | injectable · injection | PROCTER AND GAMBLE | Discontinued | 15 Sep 1960 |
| FURALAN | 50MG; 100MG | tablet · oral | CHARTWELL MOLECULAR | Discontinued | 30 Sep 1970 |
| NITROFURANTOIN | 50MG; 100MG | tablet · oral | SANDOZ | Discontinued | 25 Nov 1970 |
| NITROFURANTOIN | 100MG | tablet · oral | WATSON LABS | Discontinued | 22 Nov 1978 |
| NITROFURANTOIN | 50MG | tablet · oral | WATSON LABS | Discontinued | 5 Dec 1978 |
| NITROFURANTOIN | 25MG/5ML | suspension · oral | AMNEAL PHARMS | Discontinued | 11 May 2011 |
| NITROFURANTOIN | 50MG; 100MG | tablet · oral | ELKINS SINN | Discontinued | |
| NITROFURANTOIN | 100MG; 50MG | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | |
| NITROFURANTOIN | 50MG; 100MG | tablet · oral | WATSON LABS | Discontinued | |
| NITROFURANTOIN | 100MG | tablet · oral | WHITEWORTH TOWN PLSN | Discontinued | |
| NITROFURANTOIN | 50MG; 100MG | capsule · oral | WATSON LABS | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AURO-NITROFURANTOIN BID | 02466392 | 100 MG | CAPSULE · ORAL | AURO PHARMA INC |
| JAMP NITROFURANTOIN | 02495503 | 50 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| JAMP NITROFURANTOIN | 02495511 | 100 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| JAMP NITROFURANTOIN BID | 02544954 | 100 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| NITROFURANTOIN | 00312738 | 100 MG | TABLET · ORAL | AA PHARMA INC |
| NITROFURANTOIN | 00319511 | 50 MG | TABLET · ORAL | AA PHARMA INC |
| PMS-NITROFURANTOIN BID | 02455676 | 100 MG | CAPSULE · ORAL | PHARMASCIENCE INC |
| TEVA-NITROFURANTOIN | 02231015 | 50 MG | CAPSULE · ORAL | TEVA CANADA LIMITED |
| TEVA-NITROFURANTOIN | 02231016 | 100 MG | CAPSULE · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | NITROFURANTOIN 25 MG/5 ML SUSP | $1.68598 | per ML | 23 Sep 2026 |
| US NADAC | NITROFURANTOIN MCR 100 MG CAP | $0.23267 | per EA | 23 Sep 2026 |
| US NADAC | NITROFURANTOIN MCR 25 MG CAP | $1.53931 | per EA | 23 Sep 2026 |
| US NADAC | NITROFURANTOIN MCR 50 MG CAP | $0.16496 | per EA | 23 Sep 2026 |
| US NADAC | NITROFURANTOIN MONO-MCR 100 MG | $0.29577 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Nitrofurantoin 100mg capsules | £6.49 | 30 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Nitrofurantoin 100mg modified-release capsules | £7.11 | 14 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Nitrofurantoin 100mg tablets | £3.55 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Nitrofurantoin 25mg/5ml oral suspension sugar free | £237.10 | 300 ml | 1 Oct 2026 |
| NHS Drug Tariff | Nitrofurantoin 50mg capsules | £1.48 | 30 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Nitrofurantoin 50mg tablets | £3.21 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 6.2.1. Access group antibiotics · core
First choice: Infectious cystitis
Oral > Liquid: 25 mg per 5 mL oral liquid (EMLc) | Oral > Solid > dosage form: 100 mg; 50 mg (EMLc)
Safety signals and safety-related labeling changes
- US FDA 1 Feb 2024 FURADANTIN — safety-related labeling change
Labeling sections changed: Adverse Reactions - MHRA 26 Apr 2023 Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions
Healthcare professionals prescribing nitrofurantoin should be alert to the risks of pulmonary and hepatic adverse drug reactions and advise patients to be vigilant for the signs and symptoms in need of further investigation.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.